Clinical CareFeds Look to Pharmacists to Boost Childhood Immunization Rates
Federal officials are banking on pharmacists to undergo additional training and help reverse the slump in child immunization rates caused...
Covid-19How Pharma Money Colors Operation Warp Speed's Quest to Defeat COVID
The Trump administration relied on an unusual maneuver that allowed executives to keep investments in drug companies that would benefit...
StrategyTrump Unveils Sweeping Reforms to Lower Drug Prices
The administration will eliminate Medicare Part D drug rebates for "middlemen" and impose a Most Favored Nation pricing policy on...
StrategyPatients Struggle to Find Prescription Opioids After NY Tax Drives Out Suppliers
Pain patients in New York have lost access to vital medicine since July 2019, when the state implemented an excise...
StrategyHealth System-Owned Specialty Pharmacies Gain New Voice
Health System Owned Specialty Pharmacy Alliance to advocate for better access to more seamless care.
InnovationFive Important Questions About Pfizer's COVID-19 Vaccine
So did Pfizer's stock deserve its double-digit percentage bump? The answers to the following five questions will help us know.
Clinical CareFewer Physicians Accepting Industry Payments, But Payment Values Stay Steady
A new study highlights the importance of tracking physician conflicts of interest.
Clinical Care1-in-3 Older Adults Prescribed 'Potentially Inappropriate' Medications
The list of potentially inappropriate medications includes antidepressants, barbiturates, androgens, estrogens, nonsteroidal anti-inflammatory drugs, first-generation antihistamines, and antipsychotics.
StrategyAs Trump Touts His 'Great' COVID Drugs, the Pharma Cash Flows to Biden, Not Him
The shift away from Trump may reflect industry expectations that Democratic presidential candidate Joe Biden will win.
InnovationCleveland Clinic Names Top 10 Medical Innovations; Sickle Cell Therapy Tops the List
New medications and therapies for multiple diseases, as well as technologies, such as telehealth, hold promise to change treatment dynamics...
StrategyOld Drug Turned 'Cash Cow' as Company Pumped Price to $40K a Vial, Emails Show
The premium price when Mallinckrodt acquired H.P. Acthar gel was $31,626 for a single vial, after Questcor had hiked it...
Covid-19A Real Vaccine Before the Election? It'd Take a Miracle.
There is a small chance that Pfizer's vaccine trial will yield results by Nov. 3. But it could still take...